secwatch.observer — SEC 8-K summary
======================================

Issuer:     Syra Health Corp (SYRA)
CIK:        0001922335
Form:       8-K
Filed at:   2024-10-29T23:59:59+00:00
Accession:  0001493152-24-042779
Event type: earnings
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Syra Health reports Q3 2024 revenue $2.3M (+42% YoY); net loss narrows 69% sequentially to $417K
--------------------------------------------------------------------------------

- Revenue $2.3M, up 42% YoY from $1.6M; Population Health +36%, Healthcare Workforce +54%.
- Net loss $417,535 ($0.06 EPS) vs $1.4M ($0.21) in Q2 2024, a 69% reduction quarter-over-quarter.
- Gross margin improved to 29.7% from 17.8% in Q2 2024; operating expenses cut 37% sequentially.
- Cash $2.7M with no long-term debt; management targets profitability in 2025.
- Launched Syrenity mental health app; secured $5.8M Indiana training contract with revenue starting Q4 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1922335/000149315224042779/0001493152-24-042779-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1922335/000149315224042779/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-042779

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer